(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

GEO-CM04S1 BARDA/Project NextGen Phase 2b trial preparations ongoing with manufacturing of clinical trial materials underway ...

Drug regulator through executive order issued last August paved way for direct launch of certain categories of drugs approved ...

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 202 ...

After decades of failed attempts, scientists were optimistic that a new generation of HIV vaccine candidates would finally ...

David Geier has been hired as a senior data analyst at H.H.S. According to several people, he will examine any potential ...

The apparent choice of a major player in the anti-vaccine community to conduct an HHS study on autism has shocked vaccine ...

So far this year, the U.S. has seen more measles cases than any entire year since 2019. Bird flu is raging through poultry ...

"An adversarial collaboration on vaccines could serve as a model," write Drs. Christopher M. Worsham and Anupam B. Jena.

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

Tara Smith, a professor of epidemiology, told HuffPost that she is appalled by this appointment. “The Geiers (David and his father, Mark) were among the first to publish a link ...